Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515540 · ClinicalTrials.gov registry record · Phase 4
Brain Imaging of Lidoderm for Chronic Back Pain
A Phase 4 study of Low Back Pain, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT01515540 is a Phase 4 study of Low Back Pain that has completed, run by Northwestern University. The registered enrollment target is 38 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01515540, a Phase 4 study of Low Back Pain, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators tested whether pain decrease can be observed centrally with non-invasive brain imaging in CBP subjects receiving Lidoderm. The investigators first tested effects of 5% Lidoderm patched in an open labelled trial. Next the investigators compared the effects of Lidocaine versus Placebo patches. Three time points were evaluated: baseline (before treatment) and 6 hours and 2 weeks after treatment. The latter trial was a 2 arm, double blind, placebo controlled trial, where participants either received Lidoderm or placebo patches, without cross over.
Conditions Studied
Interventions
- DRUG placebo
- DRUG lidocaine
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2004-01 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515540
The ClinicalTrials.gov registry entry for NCT01515540 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (92% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01515540 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01515540 about?
NCT01515540 is a clinical study titled "Brain Imaging of Lidoderm for Chronic Back Pain". The investigators tested whether pain decrease can be observed centrally with non-invasive brain imaging in CBP subjects receiving Lidoderm. The investigators first tested effects of 5% Lidoderm patched in an open labelled trial. Next the investigators compared the effects of Lidocaine versus Placeb...
What is the current status of trial NCT01515540?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2004-01. Estimated completion is 2010-06.
What conditions does trial NCT01515540 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT01515540?
The interventions under investigation include: placebo (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT01515540?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01515540 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endogenous Opioid Response to Injections
RECRUITING · Phase 4
-
Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain
RECRUITING · Phase 4
-
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
RECRUITING · Phase 4
-
Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.
RECRUITING · Phase 4
-
Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.
COMPLETED · Phase 4
-
A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain.
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.